BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20179950)

  • 1. Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity.
    Yu CC; Chiou GY; Lee YY; Chang YL; Huang PI; Cheng YW; Tai LK; Ku HH; Chiou SH; Wong TT
    Childs Nerv Syst; 2010 Jul; 26(7):897-904. PubMed ID: 20179950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.
    Chen KH; Hsu CC; Song WS; Huang CS; Tsai CC; Kuo CD; Hsu HS; Tsai TH; Tsai CY; Woung LC; Chiou SH; Lu KH; Chen YW
    Childs Nerv Syst; 2010 Nov; 26(11):1605-12. PubMed ID: 20526717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells.
    Lu KH; Chen YW; Tsai PH; Tsai ML; Lee YY; Chiang CY; Kao CL; Chiou SH; Ku HH; Lin CH; Chen YJ
    Childs Nerv Syst; 2009 May; 25(5):543-50. PubMed ID: 19225784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells.
    Yang MY; Lee HT; Chen CM; Shen CC; Ma HI
    Int J Mol Sci; 2014 Jun; 15(6):11013-29. PubMed ID: 24945311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas.
    Nesterenko I; Wanningen S; Bagci-Onder T; Anderegg M; Shah K
    PLoS One; 2012; 7(11):e49219. PubMed ID: 23145127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes.
    Morrison LC; McClelland R; Aiken C; Bridges M; Liang L; Wang X; Di Curzio D; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE
    Neoplasia; 2013 Apr; 15(4):384-98. PubMed ID: 23555184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells.
    Chang CJ; Chiang CH; Song WS; Tsai SK; Woung LC; Chang CH; Jeng SY; Tsai CY; Hsu CC; Lee HF; Huang CS; Yung MC; Liu JH; Lu KH
    Childs Nerv Syst; 2012 Mar; 28(3):363-73. PubMed ID: 22249380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
    Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
    Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.
    Chen SM; Li YY; Tu CH; Salazar N; Tseng YY; Huang SF; Hsieh LL; Lui TN
    PLoS One; 2016; 11(8):e0161299. PubMed ID: 27537345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.
    Aguilera DG; Das CM; Sinnappah-Kang ND; Joyce C; Taylor PH; Wen S; Hasselblatt M; Paulus W; Fuller G; Wolff JE; Gopalakrishnan V
    J Neurooncol; 2009 Jul; 93(3):303-18. PubMed ID: 19148581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
    Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A
    PLoS One; 2016; 11(7):e0154111. PubMed ID: 27367907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of MCL1 function sensitizes the MDA-MB-231 breast cancer cells to rh-TRAIL by increasing DR4 levels.
    De Blasio A; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Tesoriere G; Scerri C; Vento R; Di Fiore R
    J Cell Physiol; 2019 Aug; 234(10):18432-18447. PubMed ID: 30912136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over Expression of BCL2 and Low Expression of Caspase 8 Related to TRAIL Resistance in Brain Cancer Stem Cells.
    Qi L; Ren K; Fang F; Zhao DH; Yang NJ; Li Y
    Asian Pac J Cancer Prev; 2015; 16(12):4849-52. PubMed ID: 26163602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis.
    Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8.
    Häcker S; Dittrich A; Mohr A; Schweitzer T; Rutkowski S; Krauss J; Debatin KM; Fulda S
    Oncogene; 2009 Sep; 28(35):3097-110. PubMed ID: 19597472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
    Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
    Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
    Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs.
    Patties I; Kortmann RD; Menzel F; Glasow A
    J Exp Clin Cancer Res; 2016 Jun; 35(1):94. PubMed ID: 27317342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro stemness characterization of radio-resistant clones isolated from a medulloblastoma cell line ONS-76.
    Sun L; Moritake T; Zheng YW; Suzuki K; Gerelchuluun A; Hong Z; Zenkoh J; Taniguchi H; Tsuboi K
    J Radiat Res; 2013 Jan; 54(1):61-9. PubMed ID: 22951319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma.
    Ahmad Z; Jasnos L; Gil V; Howell L; Hallsworth A; Petrie K; Sawado T; Chesler L
    PLoS One; 2015; 10(3):e0119834. PubMed ID: 25785590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.